For patient advocates and health economists, cases like Ekirch’s illustrate why prior authorization has become such a chronic ...

Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.

Ekirch said specialists have suggested that a series of infusions made from blood plasma called intravenous immunoglobulin -- ...

StockNews.com upgraded shares of The Cigna Group (NYSE:CI – Free Report) from a buy rating to a strong-buy rating in a research note released on Saturday morning. CI has been the topic of several ...

The Cigna Group (NYSE:CI – Get Free Report) has been assigned a consensus rating of “Buy” from the seventeen research firms that are presently covering the firm, Ratings reports. Two research analysts ...

They are mistaken about the identity of Zelis’s clients, the operation of Zelis’s solutions, and the benefits Zelis provides ...

But he was determined to make it to Paris for the exhibition of his life. David Hockney in 1987 at his home in Los Angeles, Calif. This month Louis Vuitton Foundation in Paris opens a ...

A complete guide to lease accounting for healthcare organizations Making a successful transition to the latest lease accounting requirements such as ASC 842, IFRS 16 or GASB 87 can be a complicated ...